Literature DB >> 27158389

miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression.

Ting-Yi Sun1, Hong-Jian Xie1, Hui He1, Zhen Li1, Ling-Fei Kong1.   

Abstract

MicroRNAs (miRNA) play important regulatory roles in the occurrence and development of cancers. This study aimed to investigate the effects of miR-26a on the proliferation and apoptosis of ovarian cancer cells and explore the potential mechanism. qRT-PCR was performed to measure the miR-26a expression in 46 ovarian cancer tissues, and results showed miR-26a expression reduced significantly when compared with normal ovarian tissues (P<0.05). Moreover, miR-26a expression was related to the extent of cell differentiation and clinical stage of ovarian cancer (P<0.05). miR-26a mimic was transfected into SKOV3 cells and ES2 cells, and CCK8 assay, colony formation assay and flow cytometry showed miR-26a over-expression could significantly inhibit the proliferation of ovarian cancer cells and induce their apoptosis. Bioinformatics analysis revealed Cdc6 was a target gene of miR-26a. dual-luciferase assay and validation assay showed miR-26a could act on the 3'UTR of Cdc6 to regulate Cdc6 expression. These findings suggest that miR-26a may act on the 3'UTR of Cdc6 to regulate Cdc6 expression, which then inhibit the proliferation of ovarian cancer cells and induce their apoptosis. Our findings provide a new target for the diagnosis and therapy of ovarian cancer.

Entities:  

Keywords:  Ovarian cancer; cell division cycle 6; miR-26a; proliferation

Year:  2016        PMID: 27158389      PMCID: PMC4846946     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  31 in total

Review 1.  An emerging role for the miR-26 family in cardiovascular disease.

Authors:  Basak Icli; Pranav Dorbala; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2014-06-12       Impact factor: 6.677

2.  Knockdown of Cdc6 inhibits proliferation of tongue squamous cell carcinoma Tca8113 cells.

Authors:  Chong-Jin Feng; Xiao-Wei Lu; Dong-Yuan Luo; Hui-Jun Li; Jun-Bing Guo
Journal:  Technol Cancer Res Treat       Date:  2012-09-10

3.  A human protein related to yeast Cdc6p.

Authors:  R S Williams; R V Shohet; B Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

4.  Association between the CDC6 G1321A polymorphism and the risk of cervical cancer.

Authors:  Xing-Dong Xiong; Li-Qin Zeng; Qing-Yuan Xiong; Sheng-Xiang Lu; Zhi-Zhen Zhang; Xi-Ping Luo; Xin-Guang Liu
Journal:  Int J Gynecol Cancer       Date:  2010-07       Impact factor: 3.437

5.  MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer.

Authors:  Xin Zhang; Dakai Xiao; Ziyi Wang; Yongxin Zou; Liyan Huang; Weixuan Lin; Qiuhua Deng; Hui Pan; Jiangfen Zhou; Chun Liang; Jianxing He
Journal:  Mol Cancer Res       Date:  2014-08-06       Impact factor: 5.852

6.  MiR-26a inhibits prostate cancer progression by repression of Wnt5a.

Authors:  Shijia Zhao; Xiangdong Ye; Lei Xiao; Xuexiong Lian; Yupeng Feng; Feng Li; Li Li
Journal:  Tumour Biol       Date:  2014-06-28

Review 7.  Clinically relevant microRNAs in ovarian cancer.

Authors:  Shu Zhang; Zhen Lu; Anna K Unruh; Cristina Ivan; Keith A Baggerly; George A Calin; Zongfang Li; Robert C Bast; Xiao-Feng Le
Journal:  Mol Cancer Res       Date:  2014-10-10       Impact factor: 5.852

8.  Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.

Authors:  Casina W S Kan; Michael A Hahn; Gregory B Gard; Jayne Maidens; Jung Yoon Huh; Deborah J Marsh; Viive M Howell
Journal:  BMC Cancer       Date:  2012-12-28       Impact factor: 4.430

9.  miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.

Authors:  Min Deng; Hai-lin Tang; Xi-hong Lu; Mei-yuan Liu; Xiao-min Lu; Yi-xue Gu; Ji-fang Liu; Zhi-min He
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

10.  Cdc6 is an unstable protein whose de novo synthesis in G1 is important for the onset of S phase and for preventing a 'reductional' anaphase in the budding yeast Saccharomyces cerevisiae.

Authors:  S Piatti; C Lengauer; K Nasmyth
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  11 in total

1.  Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.

Authors:  Aline Brito de Lima; Luciana Maria Silva; Nikole Gontijo Gonçales; Maria Raquel Santos Carvalho; Agnaldo Lopes da Silva Filho; Letícia da Conceição Braga
Journal:  Cancer Microenviron       Date:  2018-01-06

Review 2.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

3.  MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.

Authors:  Kati Erdmann; Knut Kaulke; Christiane Rieger; Karsten Salomo; Manfred P Wirth; Susanne Fuessel
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-25       Impact factor: 4.553

4.  LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression.

Authors:  Xin Fu; Li Zhang; Li Dan; Ke Wang; Yue Xu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

5.  miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.

Authors:  Ping Wang; Long Lv
Journal:  Oncotarget       Date:  2016-12-06

Review 6.  Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.

Authors:  Xiangyi Kong; Shun Gong; Lijuan Su; Chen Li; Yanguo Kong
Journal:  J Cell Mol Med       Date:  2017-08-10       Impact factor: 5.310

7.  mTOR Signaling Upregulates CDC6 via Suppressing miR-3178 and Promotes the Loading of DNA Replication Helicase.

Authors:  Xianjin Wu; Shenghua Li; Xing Hu; Xiaoliang Xiang; Megan Halloran; Linlin Yang; Terence M Williams; Peter J Houghton; Changxian Shen; Zhengfu He
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

8.  CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer.

Authors:  Ye-Hwan Kim; Young Joon Byun; Won Tae Kim; Pildu Jeong; Chunri Yan; Ho Won Kang; Yong-June Kim; Sang-Cheol Lee; Sung-Kwon Moon; Yung-Hyun Choi; Seok Joong Yun; Wun-Jae Kim
Journal:  J Korean Med Sci       Date:  2018-11-02       Impact factor: 2.153

9.  Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells.

Authors:  Yuna Youn; Jong-Chan Lee; Jaihwan Kim; Jae Hyeong Kim; Jin-Hyeok Hwang
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379

Review 10.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.